Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2003
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051795A2 Resin-bonded isonitriles
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119864 Farnesyl transferase inhibitors
06/26/2003US20030119853 Thiocarboxamide derivatives
06/26/2003US20030119849 Piperazine and piperidine compounds
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119791 Binding to nuclear receptor proteins; stimulating BMP-2 promoter activity
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119750 Use of dipeptidyl peptidase IV inhibitors
06/26/2003US20030115683 Novel 1,4-diamino-2-(thiazol-2-yl)benzene derivatives and dyes containing said compounds
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321463A1 Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections
06/25/2003EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003EP0847388B1 Heterocyclically substituted biphenylamide derivatives, their preparation and their use as fungicides
06/25/2003CN1426416A Cephalosporin Intermediates
06/25/2003CN1426409A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426406A Process for producing optically active sulfoxide devivative'
06/25/2003CN1426402A Novel stable crystal of thiazolidinedione derivative and process for producing same
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/24/2003US6583292 Method for the esterification of alcohols and compounds useful therefor as potential anticancer agents
06/24/2003US6583290 14-methyl epothilone derivatives
06/24/2003US6583282 Formation of a urea by reacting an aromatic carbamate with a aromatic amine
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583157 Quinolinyl and benzothiazolyl modulators
06/24/2003US6583140 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050098A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
06/19/2003WO2003050097A1 Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof
06/19/2003WO2003050096A1 Thiazole derivatives with fungicidal activity
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050062A2 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049705A2 Use of pramipexole to treat amyotrophic lateral sclerosis
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114649 Plant fungicide
06/19/2003US20030114502 Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
06/19/2003US20030114500 Nitrogen heterocycle inhibitors of aspartyl protease
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003CA2470111A1 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469342A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319185A1 Method for identifying compounds with anti-herpes activity
06/18/2003EP1318987A1 Process for resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole and compounds therefor
06/18/2003EP1318986A1 Process for preparation of 2-amino-6-(alkyl) amino-4,5,6,7-tetrahydrobenzothiazoles
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/17/2003US6579893 Related thiazolidinediones
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579871 Methods of using novel compounds as neuro-protective agents
06/17/2003US6579718 For detecting and quantifying peptides, polypeptides and proteins; sensitive, facile and does not require use of organic solvents
06/17/2003US6579633 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines
06/17/2003CA2220698C N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
06/12/2003WO2003048155A1 Thrombin inhibitors
06/12/2003WO2003048150A1 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases
06/12/2003WO2003048140A1 Azole compound and medicinal use thereof
06/12/2003WO2003048139A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholipase of group ii
06/12/2003WO2003048131A1 Intermediate for biotin and process for producing the same
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003047576A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003WO2003047575A1 Therapeutic benzamide derivatives
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109703 Antiinflammatory agents; autoimmune disease
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109555 Targeted drug delivery using sulfonamide derivatives
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109526 Azo amino acids derivatives
06/12/2003US20030109521 Aryl substituted thiazolidinones and the use thereof
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108970 Generating antibodies; quantitative analysis
06/12/2003CA2469395A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholiphase of group ii
06/12/2003CA2469228A1 Azole compound and medicinal use thereof
06/12/2003CA2469130A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317884A1 Compositions for enhancing or improving the flavor of foods or drinks and method of enhancing or improving the flavor of foods or drinks by using the same
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003CN1423640A 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
06/11/2003CN1423639A Solid state forms of 5-[[6-[(2-Fluorophenyl) methoxy]-2-naphthalenyl] methyl]-2,4-Thiazolidinedione
06/11/2003CN1422851A Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease
06/10/2003US6576765 Producing heterocyclic compounds substituted with a ((oxycarbonylamino)hydrocarbylenecarbonylamino)methyl ligand, such as isopropyl ((S)-1-((R)-1(6-fluorobenzothiazol-2-yl)-ethylcarbamoyl)-2 -methylpropyl)carbamate
06/10/2003US6576643 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 337